Targeted Drug Tagrisso Could Be Advance Against Lung Cancer

MONDAY, Feb. 6, 2023 -- The best treatment for a genetically driven form of lung cancer continues to show lasting benefits, a new clinical trial update shows. Tagrisso (osimertinib) nearly doubles disease-free survival in earlier-stage patients...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news